Team

Scientific Advisory Board Our team of world renowned experts in the fields of Plants, Research and Medicine.

Prof. Mike Dixon

Professor Mike Dixon is a professor in the School of Environmental Sciences and the Director of the Controlled Environment Systems Research Facility (CESRF) at Guelph University in Ontario.

His research is focused on phyto substance growth in controlled environments and is specifically interested in developing biological life support systems for applications in space exploration. He has been involved in multiple NASA programs.

Prof. Dixon’s work on creating environment modified atmosphere to achieve desired API’s is the basis of much of the Kensana’s research and development.

Prof. Dixon earned his PhD from Edinburgh University in Scotland and holds a postdoctoral position at the University of Toronto.

Dr. Vincent Maida

Dr. Vincent Maida, a consultant in Palliative Medicine and Wound Management, is one of Canada’s foremost experts in Cannabis-Based Medicines (CBM) with almost 3 decades of involvement with CBM-related patient advocacy, clinical experience, education, and research. He graduated with his MD, MSc, certificate in patient safety and quality improvement, and certificate as a clinical medical teacher, all from the University of Toronto. Dr. Maida was the first to report the potential for CBM to treat integumentary and wound conditions in humans. He founded VinSan Therapeutics Inc. which developed a portfolio of IP with the earliest patent priority dates globally.

Dr. Joerg Gruenwald

Dr. Joerg Gruenwald is the Founder and President of Analyze & Realize ag in Berlin, Germany, a specialised research and consulting company for nutraceuticals, dietary supplements, and natural medicines.

Dr. Gruenwald has published 13 books, including the best sellers Physician’s Desk Reference PDR for herbal medicines and over 200 scientific articles. He is editor-in-chief of the journal “Advances In Natural Therapy”.

Dr. Gruenwald has worked as advisor to the FDA Office of Dietary Supplements, on the International Advisory Board of the Research Council of Complementary Medicine.

He has served as the Chairman of the International Committee AHPA American Herbal Products Association, member of the Council for Responsible Nutrition Botanical/Quality Standards Committee, United States Pharmacopoeia (USP).

Dr. Gruenwald has performed over 100 clinical trials and numerous in vivo and in vitro studies with natural products. He holds an MS in Biology and a Ph.D. in Botany both from the University of Heidelberg.

Prof. David ‘Dedi’ Meiri

Dr. David Meiri, PhD, is Associate Professor at the Faculty of Biology at the Technion and a member of the Technion Integrated Cancer Center (TICC). Dr. Meiri holds a M.Sc. in Biochemistry and a Ph.D. in plant biotechnology from Tel Aviv University. He conducted his post-doctoral fellowship at the Ontario Cancer Institute where he focused on tumor invasion and metastasis.

During his post-doctoral studies, he expanded his knowledge in human biology and cancer pathogenesis and gained worldwide recognition as an expert in the fields of G-protein coupled receptors (GPCRs), small GTPases and cytoskeleton. Upon completion of his post-doctoral fellowship, Dr. Meiri took a position at the Technion Israel Institute of Technology, where he heads the “Laboratory of Cancer Biology and Cannabinoid Research”.

Presently, his lab investigates the therapeutic potential of phytocannabinoids, with focus on the antitumor effects of cannabinoids.

In addition to the laboratory cannabis research performed on-site, Dr. Meiri collaborates with cannabis growers, clinicians, major manufacturers and distributors of medical cannabis for the purpose of revolutionizing cannabis treatment. He is operating the “Cannabis Database Project” and his lab is currently involved in eight clinical trials covering diverse aspects of cannabis treatment such as colon disease, pain prevention, cancer treatment and epilepsy.

Prof. Donald A. Abrams

Professor Donald Abrams is a cancer and integrative medicine specialist at the UCSF Osher Center for Integrative Medicine at Mount Zion.

In addition to his role at the Osher center, he is chief of Hematology and Oncology at San Francisco General Hospital.

He is an executive committee member of the UCSF Helen Diller Family Comprehensive Cancer Center and is co-chair of the center’s program in Symptom Management, Palliative Care and Survivorship.

Prof. Abrams was on the committee of physicians who assembled the most significant compilation of medical cannabis research to date: The Health Effects of Cannabis and Cannabinoids published by the National Academies of Sciences Engineering and Medicine.

He received an B.A. in Molecular Biology from Brown University in 1972 and graduated from the Stanford University School of Medicine in 1977. After completing an Internal Medicine residency at the Kaiser Foundation Hospital in San Francisco.

Dr. Paul Verrills

Dr. Paul Verrills practices full time interventional pain management in Melbourne, Australia. He is a Fellow of the Australasian Faculty of Musculoskeletal Medicine and completed Masters in Pain Medicine under Professor Bogduk, at the University of Newcastle. He was one of the first in the world to be awarded his International Fellowship in Interventional Pain Practice. He is an Editorial Reviewer for peer-reviewed journals including Neuromodulation and Pain Medicine.

Dr. Verrills is a past Australian representative board member for the International Neuromodulation Society (INS) and is immediate past President of the Neuromodulation Society of Australia and New Zealand (NSANZ). He is also a member of the International Neuromodulation Society, Australian Pain Society, Spine Intervention Society, World Institute of Pain, The International Association for the Study of Pain, and the Spine Society of Australia.

He is director of Asia Pacific Advanced Pain Therapies Interventional program and sits on the International Pain Therapies Executive Advisory Board. Further he was honoured to recently be invited onto the inaugural Executive Emeritus Board of the American Society for Pain and Neuroscience (ASPN). In Melbourne he is a Director and Founder of Metro Pain Group, Monash House Private Hospital, Monash Clinical Research and Australian Medicinal Cannabis Service.

Our Leadership Team

Kensana Executive Team  An Experienced Team

Ken Clement

Ken has been the driving force behind Kensana and its focus on Phyto substance and medical cannabinoid standardized production and dosage. Ken has a proven track record, having already built ABcann Global (now VIVO traded on the TSX) from an idea in 2012 to a public company valued in excess of CAD$400 million when he departed in 2017. At ABcann, Ken applied innovative technology to cultivate cannabinoids on a large scale in a standardized manner.

Neil Kapp

Neil brings a wealth of business experience to Kensana with over 35 years in private and public companies. In his previous role at ABcann, Neil was Vice-President of Business Development, which involved him in fundraising, negotiating and implementing technology partnerships. Holding an Honours Bachelor of Business Administration from York University, Neil has been CFO for numerous private entities.

Lanning Ryan

John Hoff

John will lead the Company’s German team focusing on the European expansion. John is a visionary entrepreneur with extensive cannabinoid industry knowledge worldwide. He founded Sens Media and the P3 Collective. John has been an active advocate for medicinal cannabinoids and is considered as one of the premier thought leaders in the industry in Germany.

Randy Uens

Randy leads the Company’s North American business interests. Randy has over 25 years’ experience in diverse markets such as food, nutraceuticals and waste. Notably, Randy developed the Rhinobag/Bagster platform that he sold to Waste Management (WM). Randy’s interest in cannabinoids came out of his work with developing innovative omega 3 products as VP of Sales at Blue Ocean Nutra Sciences. Randy has a BA in Management Economics from the University of Guelph.

Mark Bresciano

Kensana Management Team Deep Industry Understanding

Michael Hofmann

Mike boasts nearly 20 years of industry experience in the phyto-pharmaceutical and production horticultural industry. Mike has held positions as initial Construction Project Manager, Facility Manager, and Director of Horticulture in agricultural enterprises, and has been involved with GMP production facility designs. In addition, Mike has held positions with Eurosa Gardens on Vancouver Island and German company Storsberg GaLaBau GmbH.

Luke Silverman

Luke is a marketing and business consultant with a unique depth of experience. He has spent over 10 years working for and with major companies in the US cannabinoid sector such as General Hydroponics, Lumatek Lighting, Diamond Lighting, Hawthorne Gardening and more. Over the years he has developed a comprehensive and detailed perspective of the ever changing landscape and politics of the cannabinoid industry, which helps fuel his innovative ideas that grow successful businesses

Janika Takats

Janika is a communication and marketing expert holding a BA in Cultural Studies and a MA in Cultural and Media Management. As a former CEO of a media company, she has great conceptual and strategic skills. She has 10 years of work experience in the cannabis industry working for companies in the medical and health sector as well as PR and marketing. In the past she also worked as editor-in-chief of different magazines and published a book about cannabis in Germany. 

Alex Verrils

Alex has been an integral part to the development and growth of Kensana Health in Australia, including managing the creation, design, and continued development of the CANNect Platform and eCS Clinic. Alex has qualifications in science and commerce from Monash University as well as a wealth of experience in the healthcare industry. He has developed his own start-ups before finding his passion in health. He has led teams in Australia’s leading pain speciality clinics before joining Kensana Health. 

Craig Frawley

Craig Frawley has 25 years of experience in growing and expanding start-up medical businesses.

  • Ekera Medical Ltd (Founding Director), building large integrated medical centres in
    Melbourne and Sydney;
  • MyCompounder and Precision Medicine Australia – which have laboratories in Melbourne to
    service patients around Australia as well as Asian exports;
  • CANNect Group (Founding CEO) – which provides education and patient support services to
    medicinal cannabis prescribers in Australia.

Craig is a Precision Medicine Pharmacist with Science, Entrepreneurship and Innovation degrees from Monash University, Charles Sturt University and Swinburne University.

Dr. Carrie Newbold

Dr Carrie Newbold has carried out and led applied research within a medical device field for close to two decades, from both the academic and commercial sides. She cofounded and runs a wellness company – designing and manufacturing physiotherapy self-treatment tools. The tools are used within Australia’s leading sporting bodies and within homes across the world. Carrie has qualifications in medical engineering, massage therapy and Pilates.

BE(Med) PhD, DipRemMass, CertIV Pilates Matwork

Over 100 years of combined experience in a very young industry